Latest Headlines
CATEGORY
-
2022-10-20Prof. Jean Paul Thiery, Biosyngen’s Chief Scientist, is ranked among the World’s Top 2% Clinical Scientists 2022Professor Jean Paul Thiery, Biosyngen’s Chief Scientist and Chairman of Scientific Advisory Board, is featured in the World’s Top 2% Clinical Scientists 2022. Published by John P.A.Joannidis’ of Stanford University, this ranking recognizes impactful and influential clinical researchers around the wREAD MORE -
2022-09-28The IND application of Biosyngen BRG01 Therapy was accepted by CDEGUANGZHOU, China, Sept. 28, 2022 /PRNewswire/ -- The IND application of Biosyngen BRG01 Therapy has been accepted for review by the Center for Drug Evaluation, China (CXSL2200487)（https://www.cde.org.cn/main/xxgk/listpageREAD MORE -
2022-09-28Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A BoostSINGAPORE, Sept. 28, 2022 /PRNewswire/ -- On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a base to develop the company's immunotherapy assets to address unmet needs in cancer treatment.READ MORE -
2022-05-28Embracing Win-win Cooperation - ASEAN Consul Generals, officials and representatives of chambers of commerce in Guangzhou visited BiosyngenGUANGZHOU, China, May 28, 2022 /PRNewswire/ -- On the morning of May 27, 2022, Mr. Loh Tuck Keat, Consul General of Singapore in Guangzhou, and representatives of Consulates General and Chambers of Commerce of eight countries, namely Malaysia, Philippines, Laos, Vietnam, Indonesia, Thailand and CambREAD MORE -
2022-01-15French Consul General in Guangzhou led a delegation to visit Biosyngen in China-Singapore Guangzhou Knowledge CityGUANGZHOU, ChinaJan. 15, 2022 /PRNewswire/ -- On the afternoon of January 14th, Mr. Sylvain FOURRIERE, Consul General of France in Guangzhou, and officers from consulates general of 9 countries including Britain, Canada and Switzerland visited China-Singapore Guangzhou Knowledge City and Singapore-bREAD MORE -
2021-12-29Biosyngen Pte Ltd launched biological production base for commercialization of immune cell therapeutics in ChinaGUANGZHOU, China, Dec. 29, 2021 /PRNewswire/ -- The inauguration ceremony of Biosyngen Pte. Ltd., ("Biosyngen") joint projects and Biosyngen biological production base was held in China-Singapore Guangzhou Knowledge City (CSGKC), on December 28th , 2021.READ MORE
